Who has invested in Norlase?

European Investment Bank, West Hill Capital are named among the investors backing Norlase.

Norlase Funding: $33M Raised, Series C (2025)

Norlase funding overview

Norlase is based in Ballerup, Denmark. Norlase has raised $33M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2025. The round record for Norlase runs through 2025; nothing later has been disclosed. Investors on record include European Investment Bank, West Hill Capital. 2 distinct backers are named across the disclosed rounds.

Norlase at a glance

Total raised: $33M
Latest round: Series C
Latest round date: February 2025
Headquarters: Ballerup, Denmark
Notable investors: European Investment Bank, West Hill Capital

Frequently asked about Norlase funding

How much has Norlase raised?: Norlase has raised $33M in total disclosed funding across the rounds on record.
Who has invested in Norlase?: European Investment Bank, West Hill Capital are named among the investors backing Norlase.
What was the latest Norlase funding round?: The most recent disclosed round is a Series C, announced in February 2025.
Where is Norlase based?: Norlase is based in Ballerup, Denmark.
When did Norlase last raise?: The last disclosed Norlase round closed in February 2025 at Series C.

Totals shown for Norlase aggregate every disclosed round on file. To see how that compares, browse the companies in Ballerup and the investors behind them below.

Norlase Funding: $33M Raised, Series C (2025)

Norlase funding overview

Norlase at a glance

Frequently asked about Norlase funding

Companies related to Norlase (20)

Browse related funding lists (4)